Adverum Biotechnologies Current Assets

Adverum Biotechnologies (ADVM) currently reports a current assets of $29M as of September 2025. That compares with $160M in the prior-year period — down 82.1% year over year. Use the charts on this page to explore Adverum Biotechnologies's current assets history and peer comparisons.

Adverum Biotechnologies's current assets decreased from $160M to $29M — a 82.1% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Adverum Biotechnologies reported $29M in current assets as of September 2025. That compares with $160M in the prior-year period — down 82.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $29M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Adverum Biotechnologies, and consider following ADVM for alerts when major investors trade the stock.

Adverum Biotechnologies is classified in the Healthcare sector. On current assets, it currently shows $29M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADVM with unrelated industries.